DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹336 Cr | ₹83 Cr | ₹109 Cr | ₹107 Cr | ₹108 Cr |
What is the latest Contingent Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹336 Cr |
| Mar2025 | ₹83 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹108 Cr |
How is Contingent Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹336 Cr | 304.79 | |
| Mar2025 | ₹83 Cr | -23.89 | |
| Mar2024 | ₹109 Cr | 1.77 | |
| Mar2023 | ₹107 Cr | -0.37 | |
| Mar2022 | ₹108 Cr | - | |
Compare Contingent Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹96,908.7 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| MANKIND PHARMA | ₹98,304.7 Cr | -1.5% | -3.3% | -4.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.2% |
0% |
-7.1% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses